Opioid agonist treatment dosage and patient-perceived dosage adequacy, and risk of hepatitis C infection among people who inject drugs

INTERPRETATION: Risk of HCV infection varies considerably according to dosage of opioid agonist treatment and patient-perceived adequacy, with associations indicating both protective and harmful effects relative to no exposure to opioid agonist treatment.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	CMAJ: Canadian Medical Association Journal 2019, Vol.191 (17), p.E462
Hauptverfasser:	Artenie, Andreea A, Minoyan, Nanor, Jacka, Brendan, Hoj, Stine, Jutras-Aswad, Didier, Roy, Elise, Gauvin, Lise, Zang, Geng, Bruneau, Julie
Format:	Report
Sprache:	eng
Schlagworte:	Antibodies Biological products Buprenorphine Care and treatment Dosage and administration Drug abusers Health aspects Hepatitis C Hepatitis C virus Infection Methadone Patient compliance Patient outcomes Psychological aspects Risk factors RNA
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	INTERPRETATION: Risk of HCV infection varies considerably according to dosage of opioid agonist treatment and patient-perceived adequacy, with associations indicating both protective and harmful effects relative to no exposure to opioid agonist treatment.
ISSN:	0820-3946
DOI:	10.1503/cmaj.181506